Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Procedure May Reduce Reliance on Anti-Rejection Drugs
A procedure that may limit transplant patients' reliance on powerful anti-rejection drugs has...
-- Here are the latest clinical trials, courtesy of CenterWatch:
Vaginal Atrophy
If you are a female aged 40 to 80, are post-menopausal, and have symptoms of vaginal atrophy, you may qualify for this study.
The research site is in Denver, Colo.
More...
THURSDAY, Aug. 7 -- Most people who have strokes don't act quickly enough to get the clot-dissolving treatment that can limit brain damage, a new study finds.
"One of the problems is that a lot of people don't realize that they are having a...
THURSDAY, Aug. 7 -- Blogs written by medical professionals may pose a threat to patient privacy, because the authors of the blogs may inadvertently reveal patient information, says a U.S. study that's the first to examine the issue.
The researchers...
THURSDAY, Aug. 7 -- A widely used test to monitor blood sugar levels in people with diabetes could help identify millions of people with undetected diabetes, according to a consensus statement released by a team of experts.
The hemoglobin A1c test...
Pharma Industry News
Delivery of Fluvirin supports planning and scheduling of public health influenza vaccination efforts
At least 20 million doses available by the end of September, when widespread vaccination campaigns usually begin
Additional manufacturing capacity...
'Crohn's Casts' offer insights from experts and people with Crohn's
ABBOTT PARK, Illinois August 6, 2008 - ( NYSE: ABT) – As part of its ongoing commitment to the Crohn’s disease community, Abbott today launched a series of podcasts addressing...
LA JOLLA, Calif, July 31, 2008 — Trying to reap the health benefits of exercise? Forget treadmills and spin classes, researchers at the Salk Institute for Biological Studies may have found a way around the sweat and pain. They identified...
WASHINGTON, July 31, 2008– Today U.S. Senate Special Committee on Aging Chairman Herb Kohl (D-WI), Senate Majority Whip Dick Durbin (D-IL), and Senate Committee on Health, Education, Labor, and Pensions (HELP) Committee Chairman Ted Kennedy...
Follow Up to the January 3, 2008 Communication About an Ongoing Safety Review Erythropoiesis-Stimulating Agents (ESAs) Epoetin alfa (marketed as Procrit, Epogen) Darbepoetin alfa (marketed as Aranesp)
This information reflects FDA’s current...
New Drug Approvals
First New IV Antihypertensive Treatment Approved in Ten Years
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company announced today that the U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) therapy Cleviprex (clevidipine...
Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies
EAST HANOVER, N.J., August 04, 2008 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination...
CEDAR KNolls, NJ, Aug. 1, 2008-EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received FDA approval for Cardene I.V. (nicardipine...
New Delayed Release Valproate Therapy in Small, Easy-to-Swallow Soft Gel Capsule to be Available in August 2008
MIAMI, July 30, 2008 -- Noven Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...
July 24, 2008 - The United States Food and Drug Administration (FDA) has approved Navstel Intraocular Irrigating Solution manufactured by Alcon Laboratories, Inc. Navstel is indicated for use as an intraocular irrigation during surgical procedures...
New Drug Applications
Discovery Labs Reports Progress in Responding to Surfaxin FDA Approvable Letter
WARRINGTON, Pa., Aug. 6, 2008 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. announces that it has made significant progress in addressing key remaining requirements...
KENILWORTH, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has issued a "not-approvable" letter for sugammadex sodium injection for the reversal of...
Rivaroxaban is first oral anticoagulant to achieve superior efficacy over the twice-daily injection of enoxaparin while maintaining low rates of major bleeding
No evidence of safety issues attributable to rivaroxaban after long-term...
First interleukin-6 (IL-6) inhibitor to offer new therapeutic option for rheumatoid arthritis
NUTLEY, N.J., July 29, 2008 /PRNewswire/ -- Roche today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by...
BRUSSELS, Belguim, July 29, 2008--UCB announced today that it received a not-approvable letter from the U.S. Food and Drug Administration (FDA) for lacosamide for the treatment of diabetic neuropathic pain in adults.
The company will seek...
Clinical Trials
SAN FRANCISCO--(BUSINESS WIRE)--Aug 5, 2008 - The August issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes surprising findings on Asian ethnicity and macular degeneration and on nearsightedness in school...
MEXICO CITY, August 07, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced that a retrospective analysis of six clinical trials found that anti-HIV regimens containing EPZICOM (abacavir + lamivudine) were effective in treatment-naive patients...
MEXICO CITY, August 07, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that 96-week data from the HEAT study show that once-daily EPZICOM (abacavir + lamivudine) provides comparable efficacy to once-daily Truvada(R) (tenofovir DF +...
SAVANNAH, Ga.--(BUSINESS WIRE)--Aug 7, 2008 - Health Discovery Corporation ("HDC") (OTCBB: HDVY) today announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind...
CHICAGO, August 07, 2008 /PRNewswire/ -- The American Association of Diabetes Educators (AADE) today announced results from a survey conducted by Harris Interactive highlighting communication between people with diabetes that require insulin...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
